DOCSLIB.ORG

Download PDF File

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download PDF File CASE REPORT Shibdas Chakrabarti, Srikar Darisetty, Nitesh Gupta, Pranav Ish Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India Masking of obstructive sleep apnoea by drug induced central sleep apnoea Abstract Benzodiazepines are widely prescribed hypnotic agents which have multiple proven neurological and respiratory side effects. However, literature is sparse with regards to the incidence and occurrence of new onset central sleep apnoea in individuals being treated with benzodiazepines for insomnia. We present a case report of a patient presenting with new onset central sleep apnoea secondary to long term usage of benzodiazepines, with resultant masking of his pre-existing obstructive sleep apnoea. Key words: central sleep apnoea, benzodiazepines, obstructive sleep apnea Adv Respir Med. 2019; 87: 189–193 Introduction lence, mild cognitive impairment and nocturia for a period of 1 year. He had a past history of Benzodiazepines are the most widely prescri- usage of tablet alprazolam 0.5 mg at night time, bed hypnotic agents for the short-term manage- which was prescribed by a medical practitioner ment of insomnia [1]. These agents normally exert for treatment of insomnia for the past six mon- their influence by decreasing the sleep latency ths. The patient had an Epworth sleepiness score and prolongation of total sleep time [2], however, (ESS) of 15. His body mass index (BMI) was 22. they worsen sleep quality by decreasing REM and The man was a non-smoker. On evaluation, his N3 stages of sleep. Other possible side effects inc- pulmonary function test and echocardiography lude tolerance to the hypnotic effects [3], rebound were within normal limits. There was no history insomnia upon abrupt discontinuation, reduced of any cardiovascular or cerebrovascular event. slow wave sleep [4, 5] and withdrawal effects. The man underwent a diagnostic polysomn- However, literature with regard to the incidence graphy (PSG) Level 1 which recorded the presence and occurrence of new onset central sleep apnoea of central apnoeic events (Figure 1, 2). He had an (CSA) in individuals being treated with benzo- apnoea-hypopnoea index (AHI) of 20 with more diazepines for insomnia is limited to case reports than fifty percent of events being central, hence with sparse texts on the pathophysiology behind a diagnosis of CSA was made in accordance it. We present a case of a patient with new onset with the American Academy of Sleep Medicine central sleep apnoea secondary to long-term usage (AASM) guidelines [6]. of benzodiazepines, with resultant masking of The PSG was scored manually by a sleep his pre-existing obstructive sleep apnoea (OSA). physician. In consultation with a psychiatrist, alprazolam was discontinued and the patient was Material and methods initiated on non-benzodiazepine medication (zol- pidem 5 mg once a day). The magnetic resonance A 53-year-old male, with no comorbid ill- imaging (MRI) of the brain was performed to eva- ness in the past, presented to the department of luate CSA associated with neurologic disease; it pulmonary, critical care and sleep medicine with was reported normal. On subsequent evaluation complaints of snoring, excessive daytime somno- after 2 weeks, the patient reported a subjective mild Address for correspondence: Pranav Ish, Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India; e-mail: [email protected] DOI: 10.5603/ARM.2019.0030 Received: 13.12.2019 Copyright © 2019 PTChP ISSN 2451–4934 www.journals.viamedica.pl 189 Advances in Respiratory Medicine 2019, vol. 87, no. 3, pages 189–193 Sp02 — oxygen saturation ; WK — wake; REM — rapid eye movement sleep; Resp events — respiratory events; S — supine; R — right lateral Figure 1. Hypnogram showing numerous central sleep apnoeas and desaturations and poor quality sleep (most time spent in N2 with no REM sleep) REOGA2 and LEOGA2 — right and left electrooculography; F3A2, C4A1, C3A2 and O2A1 — electroencephalograph; CEMG — Chin electromy- ography; mSnore — snoring; T flow — thermistor flow; Can flow — nasal cannula flow; THO — thoracic muscle effort; ABD — abdominal muscle effort; Effort sum — thorax and abdominal effort sum; PulseR — pulse rate; SPO2 — oxygen saturation; Body — body position Figure 2. Polysomnography five-minute window with epoch 421−430 showing central sleep apnoea in view of no effort with no flow improvement in sleep quality with ESS getting bet- te decrease in both airflow and respiratory effort. ter to 11 from an initial value of 15 over a period Usually, there is no snoring, absence of chest-ab- of two weeks. The effect of alprazolam wears off in dominal paradox and the nasal pressure or PAP 2 to 3 days as it has a half-life of around 11 hours. device flow signal is fairly rounded. However, in view of persistent daytime som- Split night titration was done and a conti- nolence, a repeated PSG was planned. Unexpecte- nuous positive airway pressure (CPAP) of 5 cm dly, in the PSG, numerous obstructive hypopno- water was sufficient to abolish all the obstructive eas were recorded with an AHI of 32 (Figure 3–5). apnoea and hypopnoea events, however, few hy- There was a complete absence of central ap- popnoeas persisted in supine REM sleep leading noeas and hypopnoeas. The present study did to a „good titration” according to the AASM not use the esophageal pressure measurements; guidelines [6]. The sleep quality improved with differentiation between obstructive and central supine REM achieved after continuous positive hypopnoea was performed manually. In general, airway pressure (CPAP) titration (Figure 6, 7). The central hypopnoeas are defined by a proportiona- patient was continued on tablet zolpidem for one 190 www.journals.viamedica.pl Shibdas Chakrabarti et al., OSA masked by CSA Sp02 — saturation of oxygen; WK — wake; REM — REM sleep; S — supine; R — right lateral; IPAP — inspiratory positive airway pressure; EPAP — expiratory positive airway pressure Figure 3. Hypnogram showing disappearance of central events and appearance of obstructive hypopneas in follow-up polysomnography which is titrated with CPAP (green arrow) achieving supine REM REOGM2 and LEOGM2 — right and left electrooculographyl F3M2, C4M1, C3M2 and O2M1 — electroencephalograph; CEMG — Chin electromy- ography; mSnore — snoring; T flow — thermistor flow; Can flow — nasal cannula flow; PatFlow — Patient flow using positive airway pressure device; THO — thoracic muscle effort; ABD — abdominal muscle effort; Effort sum — thorax and abdominal effort sum; PulseR — pulse rate; SPO2 — oxygen saturation; Body — body position; IPAP — inspiratory positive airway pressure; EPAP — expiratory positive airway pressure Figure 4. Polysomnography with ten epochs number 301−310 showing numerous obstructive hypopnoeas more week and prescribed a continuous airway diazepines have been implicated in precipitating pressure of 6 cm water for nocturnal use. The man sleep apnoea, especially central sleep apnoea is currently on follow-up on CPAP only with no (CSA) in patients with heart failure and severe sedative, and reports an improved sleep quality desaturations in patients with mild OSA [7]. and reduced daytime symptoms. The Epworth This situation is complicated by many fac- sleepiness score is now 5 with no limitation in tors, misdiagnosis of OSA as insomnia, ease of social and workplace activity. access to certain sedatives and comorbid psy- chiatric diseases. The other contributing factors Discussion are lack of awareness on the part of the physician to recognise the symptoms of choking, snoring, Usage of hypnotics for sleep induction and early morning headache suggestive of OSA and maintenance is the most common short-term ma- worsening of OSA by psychiatric medications. nagement strategy for insomnia. However, benzo- Moreover, if an airway obstruction occurs, aro- www.journals.viamedica.pl 191 Advances in Respiratory Medicine 2019, vol. 87, no. 3, pages 189–193 REOGM2 and LEOGM2 — right and left electrooculography; F3M2, C4M1, C3M2 and O2M1 — electroencephalograph; CEMG — Chin electromy- ography; mSnore — snoring; T flow — thermistor flow; Can flow — nasal cannula flow; PatFlow — Patient flow using positive airway pressure device; THO — thoracic muscle effort; ABD — abdominal muscle effort; Effort sum — thorax and abdominal effort sum; PulseR — pulse rate; SPO2 — oxygen saturation; Body — body position; IPAP — inspiratory positive airway pressure; EPAP — expiratory positive airway pressure Figure 5. Polysomnography with ten epochs number 721−731 showing no residual hypopnoeas on positive airway pressure of 5 cm water 45.9% 43.8% WK (19%) WK (10.6) 4.6% REM (0.0)% REM (14.3)% 1,4% N1 (33.6%) 10.6% N1 (26.7%) 33.6% 19% N2 (45.9%) 26.7% N2 (43.8%) 14.3% N3 (1.4%) N3 (4.6%) WK — wake; REM — rapid eye movement sleep WK — wake; REM — rapid eye movement sleep Figure 6. No REM and minimal N3 stage activity recorded in initial Figure 7. Improvement in sleep quality with REM contributing to 14% polysomnography when patient was taking Alprazolam of sleep after stopping alprazolam and on PAP titration usals allow the patient to correct the apnoea. The occurrence of CSA has been reported Benzodiazepines can prevent arousal by causing by benzodiazepines because as central nervous sedation, thereby worsening the obstruction system depressants, these drugs decrease the and associated desaturation. However, another central respiratory drive which also has been school of thought reasons that as
Load more

Recommended publications
  • ON ATTRACTION of SLIME MOULD PHYSARUM POLYCEPHALUM to PLANTS with SEDATIVE PROPERTIES 1. Introduction Physarum Polycephalum Belo
    ON ATTRACTION OF SLIME MOULD PHYSARUM POLYCEPHALUM TO PLANTS WITH SEDATIVE PROPERTIES ANDREW ADAMATZKY Abstract. A plasmodium of acellular slime mould Physarum polycephalum is a large single cell with many nuclei. Presented to a configuration of attracting and repelling stimuli a plasmodium optimizes its growth pattern and spans the attractants, while avoiding repellents, with efficient network of protoplasmic tubes. Such behaviour is interpreted as computation and the plasmodium as an amorphous growing biologi- cal computer. Till recently laboratory prototypes of slime mould computing devices (Physarum machines) employed rolled oats and oat powder to represent input data. We explore alternative sources of chemo-attractants, which do not require a sophis- ticated laboratory synthesis. We show that plasmodium of P. polycephalum prefers sedative herbal tablets and dried plants to oat flakes and honey. In laboratory experi- ments we develop a hierarchy of slime-moulds chemo-tactic preferences. We show that Valerian root (Valeriana officinalis) is strongest chemo-attractant of P. polycephalum outperforming not only most common plants with sedative activities but also some herbal tablets. Keywords: Physarum polycephalum, slime mould, valerian, passion flower, hops, ver- vain, gentian, wild lettuce, chemo-attraction 1. Introduction Physarum polycephalum belongs to the species of order Physarales, subclass Myxo- gastromycetidae, class Myxomycetes, division Myxostelida. It is commonly known as a true, acellular or multi-headed slime mould. Plasmodium is a `vegetative' phase, single cell with a myriad of diploid nuclei. The plasmodium looks like an amorphous yellowish mass with networks of protoplasmic tubes. The plasmodium behaves and moves as a giant amoeba. It feeds on bacteria, spores and other microbial creatures and micro- particles (Stephenson & Stempen, 2000).
    [Show full text]
  • Yerevan State Medical University After M. Heratsi
    YEREVAN STATE MEDICAL UNIVERSITY AFTER M. HERATSI DEPARTMENT OF PHARMACY Balasanyan M.G. Zhamharyan A.G. Afrikyan Sh. G. Khachaturyan M.S. Manjikyan A.P. MEDICINAL CHEMISTRY HANDOUT for the 3-rd-year pharmacy students (part 2) YEREVAN 2017 Analgesic Agents Agents that decrease pain are referred to as analgesics or as analgesics. Pain relieving agents are also called antinociceptives. An analgesic may be defined as a drug bringing about insensibility to pain without loss of consciousness. Pain has been classified into the following types: physiological, inflammatory, and neuropathic. Clearly, these all require different approaches to pain management. The three major classes of drugs used to manage pain are opioids, nonsteroidal anti-inflammatory agents, and non opioids with the central analgetic activity. Narcotic analgetics The prototype of opioids is Morphine. Morphine is obtained from opium, which is the partly dried latex from incised unripe capsules of Papaver somniferum. The opium contains a complex mixture of over 20 alkaloids. Two basic types of structures are recognized among the opium alkaloids, the phenanthrene (morphine) type and the benzylisoquinoline (papaverine) type (see structures), of which morphine, codeine, noscapine (narcotine), and papaverine are therapeutically the most important. The principle alkaloid in the mixture, and the one responsible for analgesic activity, is morphine. Morphine is an extremely complex molecule. In view of establish the structure a complicated molecule was to degrade the: compound into simpler molecules that were already known and could be identified. For example, the degradation of morphine with strong base produced methylamine, which established that there was an N-CH3 fragment in the molecule.
    [Show full text]
  • Receives Fda Approval for the Treatment of Insomnia
    AMBIEN CR™ (ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS) CIV RECEIVES FDA APPROVAL FOR THE TREATMENT OF INSOMNIA First and Only Extended-Release Prescription Sleep Medication Indicated for Sleep Induction and Maintenance Covers Broad Insomnia Population Paris, France, September 6, 2005 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved AMBIEN CR™ (zolpidem tartrate extended-release tablets) CIV, a new extended-release formulation of the number ® one prescription sleep aid, AMBIEN (zolpidem tartrate) CIV, for the treatment of insomnia. AMBIEN CR is non-narcotic and a non-benzodiazepine, formulated to offer a similar safety profile to AMBIEN with a new indication for sleep maintenance, in addition to sleep induction. AMBIEN CR is the first and only extended-release prescription sleep medication to help people with insomnia fall asleep fast and maintain sleep with no significant decrease in next day performance. AMBIEN CR, a bi-layered tablet, is delivered in two stages. The first layer dissolves quickly to induce sleep. The second layer is released more gradually into the body to help provide more continuous sleep. “Insomnia is a significant public health problem, affecting millions of Americans. Insomnia impacts daily activities and is associated with increased health care costs,” said James K. Walsh, PhD, Executive Director and Senior Scientist, Sleep Medicine and Research Center at St. Luke's Hospital in St. Louis, Missouri. “Helping patients stay asleep is recognized as being as important as helping them fall asleep,” said Walsh. “Ambien CR has shown evidence of promoting sleep onset and more continuous sleep".
    [Show full text]
  • Herbal Remedies and Their Possible Effect on the Gabaergic System and Sleep
    nutrients Review Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep Oliviero Bruni 1,* , Luigi Ferini-Strambi 2,3, Elena Giacomoni 4 and Paolo Pellegrino 4 1 Department of Developmental and Social Psychology, Sapienza University, 00185 Rome, Italy 2 Department of Neurology, Ospedale San Raffaele Turro, 20127 Milan, Italy; [email protected] 3 Sleep Disorders Center, Vita-Salute San Raffaele University, 20132 Milan, Italy 4 Department of Medical Affairs, Sanofi Consumer HealthCare, 20158 Milan, Italy; Elena.Giacomoni@sanofi.com (E.G.); Paolo.Pellegrino@sanofi.com (P.P.) * Correspondence: [email protected]; Tel.: +39-33-5607-8964; Fax: +39-06-3377-5941 Abstract: Sleep is an essential component of physical and emotional well-being, and lack, or dis- ruption, of sleep due to insomnia is a highly prevalent problem. The interest in complementary and alternative medicines for treating or preventing insomnia has increased recently. Centuries-old herbal treatments, popular for their safety and effectiveness, include valerian, passionflower, lemon balm, lavender, and Californian poppy. These herbal medicines have been shown to reduce sleep latency and increase subjective and objective measures of sleep quality. Research into their molecular components revealed that their sedative and sleep-promoting properties rely on interactions with various neurotransmitter systems in the brain. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a major role in controlling different vigilance states. GABA receptors are the targets of many pharmacological treatments for insomnia, such as benzodiazepines. Here, we perform a systematic analysis of studies assessing the mechanisms of action of various herbal medicines on different subtypes of GABA receptors in the context of sleep control.
    [Show full text]
  • EEG Connectivity Measures and Their Application to Assess the Depth of Anaesthesia and Sleep
    UNIVERSITY OF SOUTHAMPTON EEG connectivity measures and their application to assess the depth of anaesthesia and sleep by Giulia Lioi A thesis submitted in partial fulfillment for the degree of Doctor of Philosophy in the Engineering and the Environment Institute of Sound and Vibration Research January 2018 Declaration of Authorship I, Giulia Lioi, declare that this thesis titled, `EEG connectivity measures and their application to assess the depth of anaesthesia and sleep' and the work presented in it are my own. I confirm that: This work was done wholly or mainly while in candidature for a research degree at this University. Where any part of this thesis has previously been submitted for a degree or any other qualification at this University or any other institution, this has been clearly stated. Where I have consulted the published work of others, this is always clearly at- tributed. Where I have quoted from the work of others, the source is always given. With the exception of such quotations, this thesis is entirely my own work. I have acknowledged all main sources of help. Where the thesis is based on work done by myself jointly with others, I have made clear exactly what was done by others and what I have contributed myself. iii iv Parts of this work have been published as: Conference Papers Lioi G, Bell SL, Smith DC, Simpson DM. Characterization of functional brain connectivity networks in slow wave sleep. PGBiomed 2015, Liverpool, Germany. Lioi G, Bell S L and Simpson D M 2016. Changes in Functional Brain Connectivity in the Transition from Wakefulness to Sleep in different EEG bands.
    [Show full text]
  • Modeling the Association Between Smoking and Sleep Fragmentation Using Log-Linear Models
    Modeling the Association between Smoking and Sleep Fragmentation Using Log-Linear Models by Gina M. Norato A thesis submitted to The Johns Hopkins University in conformity with the requirements for the degree of Master of Science Baltimore, Maryland April, 2016 Copyright 2016 by Gina Norato All rights reserved Abstract Given that the etiology of poor sleep quality in regards to cigarette smoking is not well-defined, it is of interest to further investigate the risk of transition be- tween various sleep stages for never, current, and former smokers. Polysomnog- raphy and clinical data from 5139 participants of the Sleep Heart Health Study were used for the current analysis. A log-linear generalized estimating equation (GEE) modeling approach was used, adjusted for demographic covariates and comorbidities. Previous literature has described the use of this approach as a computationally faster alternative to multi-state survival models. Compared to never smokers, former smokers transition more often into wake, from non-REM and REM sleep (NW: 1.05 (CI 1.02, 1.09); RW: 1.06 (CI 1.02, 1.11)). Current smokers are more likely to transition out of non-REM into wake (1.07 (CI 1.02-1.13)), and correspondingly less likely to transition into REM sleep from non-REM sleep (0.91 (CI 0.87-0.96)). Moreover, current smokers have less risk for transition out of REM sleep (RN: 0.87 (CI 0.80-0.94); RW: 0.88 (CI 0.82-0.95)). In more detailed analyses that characterized sleep into five states, former smokers again show increased transitions to wakefulness, and also seem to have highly altered stage 2 sleep.
    [Show full text]
  • Abnormal Sleep Spindles, Memory Consolidation, and Schizophrenia
    CP15CH18_Manoach ARjats.cls April 17, 2019 13:18 Annual Review of Clinical Psychology Abnormal Sleep Spindles, Memory Consolidation, and Schizophrenia Dara S. Manoach1,2 and Robert Stickgold3 1Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA; email: [email protected] 2Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA 3Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215; email: [email protected] Annu. Rev. Clin. Psychol. 2019. 15:451–79 Keywords First published as a Review in Advance on cognition, endophenotype, genetics, memory, schizophrenia, sleep, spindles February 20, 2019 The Annual Review of Clinical Psychology is online at Abstract clinpsy.annualreviews.org There is overwhelming evidence that sleep is crucial for memory consol- https://doi.org/10.1146/annurev-clinpsy-050718- idation. Patients with schizophrenia and their unaffected relatives have a 095754 specific deficit in sleep spindles, a defining oscillation of non-rapid eye Access provided by 73.61.23.229 on 05/29/19. For personal use only. Copyright © 2019 by Annual Reviews. movement (NREM) Stage 2 sleep that, in coordination with other NREM All rights reserved oscillations, mediate memory consolidation. In schizophrenia, the spindle Annu. Rev. Clin. Psychol. 2019.15:451-479. Downloaded from www.annualreviews.org deficit correlates with impaired sleep-dependent memory consolidation, positive symptoms, and abnormal thalamocortical connectivity. These re- lations point to dysfunction of the thalamic reticular nucleus (TRN), which generates spindles, gates the relay of sensory information to the cortex, and modulates thalamocortical communication.
    [Show full text]
  • Insomnia in the Elderly: Update on Assessment and Management
    To see other CME articles, go to: www.cmegeriatrics.ca www.geriatricsjournal.ca If you are interested in receiving this publication on a regular basis, please consider becoming a member. INSOMNIA IN THE ELDERLY: UPDATE ON ASSESSMENT AND MANAGEMENT Canadian Geriatrics Society Abstract Insomnia disorder is one of the most common sleep-wake disorders seen Soojin Chun in the geriatric population, and is associated with multiple psychiatric MSc., MD FRCP(C) and medical consequences. Insomnia is a subjective complaint of Geriatric Psychiatry difficulty falling and/or staying asleep, or experiencing non-restorative Subspecialty Resident sleep, associated with significant daytime consequences including (PGY-6), University of difficulty concentrating, fatigue and mood disturbances. There is no Ottawa single diagnostic tool to assess insomnia. Consequently, an insomnia assessment requires thorough history taking including a sleep inquiry, Elliott Kyung Lee medical history, psychiatric history, substance use history and a relevant MD, FRCP(C), D. ABPN physical examination. Insomnia is often multifactorial in origin, and Sleep Med, Addiction routinely is associated with multiple other psychiatric and medical Psych, D. ABSM, F. AASM, disorders. Therefore, predisposing, precipitating and perpetuating factors F. APA, Sleep Specialist, must be carefully examined in the context of an evaluation of insomnia Royal Ottawa Mental symptoms. Other specific sleep assessments (e.g., overnight Health Centre, Assistant polysomnography) can be completed to rule out other sleep-wake Professor, University of disorders. For management, a cognitive-behavioural approach (including Ottawa sleep restriction therapy, stimulus control therapy) is commonly accepted as an effective, first-line treatment for insomnia disorder. Corresponding Author: A brief version of CBT-I focusing on behavioural interventions (Brief Elliott Kyung Lee Behavioural Treatment of Insomnia, BBT-I) has also demonstrated efficacy in the geriatric patient population.
    [Show full text]
  • A Acetylcholine Anticholinergic Drugs, 49 Cholinergic Wake-Promoting
    Index A C Acetylcholine Cataplexy anticholinergic drugs, 49 GHB, 37 cholinergic wake-promoting system, 48 narcolepsy type 1, 215 cholinesterase inhibitors, 48–49 narcolepsy type 2, 215 milameline, 49 sleep-promoting orexinergic inhibitors, 46 nicotine, 49 SXB, 238–240 receptors, 48 tricyclic antidepressants, 253 sleep-promoting cholinergic Cell replacement therapy, 253 inhibitors, 49 Central sleep apnea (CSA) syndrome, 76 Adenosine Cheyne–Stokes breathing (CSB), 76 adenosine-mediated sleep-promoting Cholinesterase inhibitors system, 41 donepezil, 49 receptors, 42 physostigmine, 48 sleep-promoting adenosine receptor Chronic insomnia agonists, 42 dose discrimination, lack of, 168 wake-promoting adenosine receptor psychiatric comorbidities, 169 antagonists, 42 short-term efficacy and long-term safety, Amantadine, 77 167–168 Armodafinil sleep induction and maintenance, 168–169 chemical structure, 212 Chronic obstructive sleep apnea multiple sclerosis, 222 (OSA), 178–179 narcolepsy, 218 Chronic primary insomnia obstructive sleep apnea, 219–221 adverse effects, 165, 167 pharmacokinetics, 214 comorbid psychiatric disorders, 164 R enantiomer, 213 double-blind trial, 164 safety, 224–225 efficacy, 165 shift work disorder, 223 long-term trial, 165 open-label extension phase, 165 post hoc analysis, 165–166 B psychomotor performance, 164–165 Benzodiazepine Withdrawal Symptom rebound insomnia, 164 Questionnaire (BWSQ), 183 WASO, 164–165 © Springer International Publishing Switzerland 2015 289 A. Guglietta (ed.), Drug Treatment of Sleep Disorders, Milestones
    [Show full text]
  • Individual Characteristics of the Sleep Electroencephalogram As Markers of Intelligence– Effects in a Broad Age and Intelligence Range
    Individual Characteristics of the Sleep Electroencephalogram as Markers of Intelligence– Effects in a Broad Age and Intelligence Range Doctoral thesis Péter Przemyslaw Ujma Semmelweis University Doctoral School of Mental Health Sciences Advisor: Róbert Bódizs, PhD, chief research fellow Official Reviewers: Gábor Csukly, MD, Ph.D., lecturer Kristóf Kovács, Ph.D., chief research fellow President of the Qualification Committee: István Bitter, MD, DSc, professor Members of the Qualification Committee:Pál Czobor, MD, Ph.D., associate professor Dezs ő Németh, Ph.D., associate professor Budapest 2015 Table of Contents List of abbreviations ......................................................................................................... 3 1. Introduction .................................................................................................................. 3 1.1. Sleep as a Biological State ................................................................................................. 5 1.1.1. Basic Features and Regulation of Sleep ...................................................................... 5 1.1.2. Potential Functions of Sleep, Slow Waves and Spindles .......................................... 11 1.1.3. Methodological Problems – Measuring Spectra and Sleep Spindles ........................ 23 1.2. Intelligence ....................................................................................................................... 28 1.2.1. Traditional Views of Intelligence .............................................................................
    [Show full text]
  • Antibiotic-Induced Depletion of the Gut Microbiota Reduces Nocturnal Sleep in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/199075; this version posted October 5, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Sleep and the gut microbiome: antibiotic-induced depletion of the gut microbiota reduces nocturnal sleep in mice Jonathan Lendrum1, a, *, Bradley Seebach1, Barrett Klein1, Sumei Liu1 1Department of Biology, University of Wisconsin – La Crosse, 1725 State St, La Crosse, WI 54601, USA aCorrespondence (J. Lendrum): Tel: +1(920)-850-7883. E-mail: [email protected] *Permanent Address (J. Lendrum): 5600 11th Ave S, Minneapolis, MN 55417, USA Highlights -14 d broad-spectrum antibiotic treatment effectively depletes the gut microbiota. -Gut microbiota depletion reduces nocturnal sleep, but not diurnal sleep. -Gut microbiota depletion increases nocturnal locomotion, but not diurnal locomotion. -Antibiotics may be insomnogenic: implications for idiopathic sleep disorders. Abstract Several bacterial cell wall components such as peptidoglycan and muramyl peptide are potent inducers of mammalian slow-wave sleep when exogenously administered to freely behaving animals. It has been proposed that the native gut microflora may serve as a quasi-endogenous pool of somnogenic bacterial cell wall products given their quantity and close proximity to the intestinal portal. This proposal suggests that deliberate manipulation of the host’s intestinal flora may elicit changes in host sleep behavior. To test this possibility, we evaluated 24 h of sleep-wake behavior after depleting the gut microbiota with a 14 d broad-spectrum antibiotic regimen containing high doses of ampicillin, metronidazole, neomycin, and vancomycin.
    [Show full text]
  • Thalidomide-A New Nonbarbiturate Sleep-Inducing Drug
    THALIDOMIDE-A NEW NONBARBITURATE SLEEP-INDUCING DRUG From the Departments of Medicine (Division of Cliniral LOUIS LG~YGNA, M.D. Pharmacology), Pharmacology, and Experimental Thera- peutics, Johns Hopkins C’niversity School of Medicine BALTIMORE:,MD. (Received for publication I>ec. 9, 1959) HALIDOMIDE* is the generic name for IK-phthalyl-glutamic acid imide, a T compound which has been employed in Europe for several years as a sedative-hypnotic. It is chemically related to glutethimide (Doriden), another sedative-hypnotic, and to bemegride (Megimide), a convulsant analeptic. Unpublished data supplied by the Scientific Division of The William S. Merrell Company indicate that thalidomide is a central nervous system depressant in mice, reducing spontaneous motor activity slightly in doses of 30 mg. per kilogram and to a considerable degree in dosesof 100mg. perkilogram. Thalidomide at doses of 100 mg. per kilogram, orally or intraperitoneally, does not produce loss of righting reflexes in mice, rats, cats, dogs, or monkeys. Large quantities of drug (up to 4 Gm. per kilogram), by mouth or intraperitoneally, failed to produce death in mice over a 72-hour observation period. This lack of toxicity of large doses is most likely related to the insolubility of the compound and a consequent limitation in absorption. Uncontrolled German trials’-” have reported thalidomide to be an effective hypnotic drug when administered in doses of 50 to 200 mg. In a controlled English trial by Salter, Lodge-Patch, and Hare ,5 50 or 100 mg. of drug has been reported to produce sleep as quickly as 200 mg. of secobarbital, and the duration of sleep after 100 mg.
    [Show full text]